CA23971A - Composition medecinale pour le traitement les maladies de matrice, cancers, ulceres, brulures, etc. - Google Patents

Composition medecinale pour le traitement les maladies de matrice, cancers, ulceres, brulures, etc.

Info

Publication number
CA23971A
CA23971A CA000023971A CA23971DA CA23971A CA 23971 A CA23971 A CA 23971A CA 000023971 A CA000023971 A CA 000023971A CA 23971D A CA23971D A CA 23971DA CA 23971 A CA23971 A CA 23971A
Authority
CA
Canada
Prior art keywords
womb
scalds
ulcers
cancers
cure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000023971A
Other languages
English (en)
Inventor
Philomene Dumais
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Publication date
Application granted granted Critical
Publication of CA23971A publication Critical patent/CA23971A/fr
Expired legal-status Critical Current

Links

CA000023971A Composition medecinale pour le traitement les maladies de matrice, cancers, ulceres, brulures, etc. Expired CA23971A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA23971T

Publications (1)

Publication Number Publication Date
CA23971A true CA23971A (fr) 1886-05-04

Family

ID=45140514

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000023971A Expired CA23971A (fr) Composition medecinale pour le traitement les maladies de matrice, cancers, ulceres, brulures, etc.

Country Status (1)

Country Link
CA (1) CA23971A (fr)

Similar Documents

Publication Publication Date Title
MX2022013163A (es) Anticuerpo contra nectin-4 y aplicacion del mismo.
WO2021229507A3 (fr) Méthodes, thérapies et utilisations pour le traitement du cancer
WO2021262910A3 (fr) Tubulysines et conjugués tubulysines-protéines
WO2020132658A3 (fr) Tubulysines et conjugués tubulysines-protéines
WO2022106902A8 (fr) Dérivés de benzènesulfonamide et leurs utilisations
WO2021257697A8 (fr) Composés et procédés de blocage de l'apoptose et d'induction de l'autophagie
WO2023277583A8 (fr) Nouveau composé induisant la dégradation de la protéine plx1
MX2025001068A (es) Derivados arilos tricíclicos, y composiciones y métodos de los mismos
CA3199014A1 (fr) Polytherapie pour le traitement d'une hepatopathie
CA33009A (fr) Liniment ou composition medicale pour la guerison des rhumatismes, contusions, maladies de l'epine d'orsale, etc.
CA23887A (fr) Composition pour la chevelure
HK40107716A (en) Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
CA23433A (fr) Liniment pour le rhumatisme, etc.
CA26293A (fr) Composition medecinale pour les maladies cutanees
CA3284404A1 (fr) Dérivés de 2-azaspiro[3.3]heptane utilisés comme inhibiteurs de stat3 pour le traitement du cancer
HK40074804A (en) 1,2,4-oxadiazol-5-one derivatives for the treatment of cancer
HK40130970A (en) Combination therapy for the treatment of cancer
HK40114518A (en) Combination therapy for the treatment of cancer
CA3283535A1 (fr) Composés tricycliques pour le traitement du cancer
CA23368A (fr) Seringue
CA25458A (fr) Seringue
HK40092016A (en) Anti-b7h3 antibodies for the treatment of cancer
MX2025005561A (es) Combinacion de lurbinectedina y doxorrubicina
HK40114414A (en) Dr5-targeting multabodies for the treatment of cancer
HK40074280A (en) Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (dlk) kinase for the treatment of disease